GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrobiosystems Co Ltd (SZSE:301080) » Definitions » Piotroski F-Score

Acrobiosystems Co (SZSE:301080) Piotroski F-Score : 4 (As of Apr. 23, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Acrobiosystems Co Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Acrobiosystems Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Acrobiosystems Co's Piotroski F-Score or its related term are showing as below:

SZSE:301080' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 5   Max: 5
Current: 4

During the past 8 years, the highest Piotroski F-Score of Acrobiosystems Co was 5. The lowest was 4. And the median was 5.


Acrobiosystems Co Piotroski F-Score Historical Data

The historical data trend for Acrobiosystems Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrobiosystems Co Piotroski F-Score Chart

Acrobiosystems Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial N/A 5.00 4.00 5.00 4.00

Acrobiosystems Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 6.00 6.00 6.00 4.00

Competitive Comparison of Acrobiosystems Co's Piotroski F-Score

For the Biotechnology subindustry, Acrobiosystems Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acrobiosystems Co's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acrobiosystems Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Acrobiosystems Co's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was 30.672 + 26.023 + 26.795 + 40.342 = ¥123.8 Mil.
Cash Flow from Operations was 32.063 + 3.422 + 53.221 + -3.999 = ¥84.7 Mil.
Revenue was 145.999 + 153.402 + 164.085 + 181.537 = ¥645.0 Mil.
Gross Profit was 135.171 + 138.657 + 149.466 + 163.243 = ¥586.5 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was
(2813.498 + 2812.122 + 2875.625 + 2801.124 + 2914.608) / 5 = ¥2843.3954 Mil.
Total Assets at the begining of this year (Dec23) was ¥2,813.5 Mil.
Long-Term Debt & Capital Lease Obligation was ¥24.9 Mil.
Total Current Assets was ¥2,235.8 Mil.
Total Current Liabilities was ¥278.9 Mil.
Net Income was 45.05 + 46.582 + 36.523 + 25.438 = ¥153.6 Mil.

Revenue was 136.865 + 131.534 + 144.18 + 131.073 = ¥543.7 Mil.
Gross Profit was 124.617 + 119.885 + 132.467 + 119.196 = ¥496.2 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was
(2735.96 + 2766.184 + 2726.492 + 2793.15 + 2813.498) / 5 = ¥2767.0568 Mil.
Total Assets at the begining of last year (Dec22) was ¥2,736.0 Mil.
Long-Term Debt & Capital Lease Obligation was ¥38.5 Mil.
Total Current Assets was ¥2,227.0 Mil.
Total Current Liabilities was ¥185.1 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Acrobiosystems Co's current Net Income (TTM) was 123.8. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Acrobiosystems Co's current Cash Flow from Operations (TTM) was 84.7. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=123.832/2813.498
=0.04401354

ROA (Last Year)=Net Income/Total Assets (Dec22)
=153.593/2735.96
=0.05613861

Acrobiosystems Co's return on assets of this year was 0.04401354. Acrobiosystems Co's return on assets of last year was 0.05613861. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Acrobiosystems Co's current Net Income (TTM) was 123.8. Acrobiosystems Co's current Cash Flow from Operations (TTM) was 84.7. ==> 84.7 <= 123.8 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=24.891/2843.3954
=0.00875397

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=38.502/2767.0568
=0.01391442

Acrobiosystems Co's gearing of this year was 0.00875397. Acrobiosystems Co's gearing of last year was 0.01391442. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=2235.759/278.861
=8.01746748

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=2226.996/185.092
=12.03183282

Acrobiosystems Co's current ratio of this year was 8.01746748. Acrobiosystems Co's current ratio of last year was 12.03183282. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Acrobiosystems Co's number of shares in issue this year was 120.817. Acrobiosystems Co's number of shares in issue last year was 119.954. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=586.537/645.023
=0.90932726

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=496.165/543.652
=0.91265184

Acrobiosystems Co's gross margin of this year was 0.90932726. Acrobiosystems Co's gross margin of last year was 0.91265184. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=645.023/2813.498
=0.22926016

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=543.652/2735.96
=0.19870612

Acrobiosystems Co's asset turnover of this year was 0.22926016. Acrobiosystems Co's asset turnover of last year was 0.19870612. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+0+1+0+0+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Acrobiosystems Co has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Acrobiosystems Co  (SZSE:301080) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Acrobiosystems Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Acrobiosystems Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Acrobiosystems Co Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Hongda North Road, 4th Floor, Building 4, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176
Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.

Acrobiosystems Co Headlines

No Headlines